Study Name:
Phase II Study of LUNG STereotactic Adaptive Ablative Radiotherapy for Central and Ultracentral Tumors (LUNG STAAR)
Targeted Disease(s):
Lung Cancer
Purpose of Study:
The purpose of this research is to offer patients with centrally located early-stage non-small cell lung cancer (NSCLC) who are NOT candidates for surgery the opportunity to receive stereotactic body radiation therapy (SBRT).
Study Dates:
May 2, 2022 - October 1, 2032
Study Design:
Observational Design
Study Location:
Nationwide
Lead Institution:
Miami Cancer Institute at Baptist Health, Inc.
Funding Source:
View Ray Inc.
Sponsors:
Miami Cancer Institute at Baptist health, Inc.
Contact:
Rupesh Kotecha, M.D.
Contact Phone: 786-596-2000
Contact Email: rupeshk@baptisthealth.net
Sponsor:
Miami Cancer Institute at Baptist health, Inc.
